I agree, but our hair always grows back Staying a strong no here too, (and moreso on principle as well)
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans